×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Subhanu Saxena
Subhanu Saxena
Cipla Q1 profit down 44%, US biz drags revenue; MD to step down
Cipla launches generic hepatitis C drug in India
Cipla to pay for InvaGen, Exelan mostly through own funds
Cipla to acquire two US pharma companies for $550 mn
Aiming to achieve 70-80% organic growth: Cipla
Cipla falls 5% on fears of Nexium sales slowdown post Q1
Cipla sees senior, mid-mgmt level exodus in last 3-4 months
Cipla to sharpen focus on emerging markets in growth push
Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets
Cipla to launch generic Hepatitis C drug 'Hepcvir' in India
Cipla awarded $188.95mn tender by Global Fund for ARV drugs
Cipla forms JV in Morocco to expand position in African mkt
Discussing partnerships, have done in-licensing deals:Cipla
Respiratory business expected to double in future: Cipla
Cipla appoints Sameer Goel as India Head
Cipla acquires Croatia-based Celeris
H1 inline; Cipla Medpro fully integrated: Cipla MD
Cipla appoints MK Hamied as Executive Vice-Chairman
Medpro buy to boost Africa biz sales by 2-3%: Cipla
Cipla mgmt rejig: Time to act as godfather says YK Hamied
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio